YTHDF2 and prostate cancer: Overexpressed YTHDF2 could reverse the inhibitory role of miR-495 and decreased the m6A levels of mps one binder kinase activator 3B (MOB3B) to promote the proliferation and migration of prostate cancer cells[67].